Skip to main content
Premium Trial:

Request an Annual Quote

Roche, Swiss Non-profit Team to Study IVD Use in Developing Countries

NEW YORK (GenomeWeb News) — Roche Diagnostics will work with the Foundation for Innovative New Diagnostics to study the potential uses of in vitro diagnostics for “poverty related” diseases, the groups said today.
 
Under the plan, FIND, a Swiss non-profit that promotes health in developing countries, will conduct product evaluation studies with Roche’s help. These programs will attempt to adapt IVD technology to the needs of underprivileged populations, especially those at risk for tuberculosis, sleeping sickness, and malaria.  
 
FIND CEO Giorgio Roscigno said the group is “hopeful that IVD tools that are efficient, user-friendly, and affordable can significantly increase the quality of diagnosis in these regions.”
 
FIND is funded by the Bill & Melinda Gates Foundation, the US Agency for International Development, the European Union and the Dutch Government.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.